Early trial of new breast cancer treatment reduces regimen to a few days
A recent phase one clinical trial at UT Southwestern successfully decreased early-stage breast cancer treatments from nearly two months to just days. The new approach hopes to ease the burden for cancer patients who are already coping with an upsetting diagnosis.
